HOME - Companies - News
 
 
26 May 2026

Dentsply Sirona Summit Nears Full Capacity


With just five weeks to go, Dentsply Sirona’s Implant Solutions World Summit 2026 is seeing strong global demand, with registration continuing to grow and most masterclasses now fully booked.

The Implant Solutions World Summit 2026, taking place June 25–27 in Gothenburg, Sweden, will bring together clinicians and lab technicians from around the world for three days of science-driven education, collaboration, and innovation. Built around the theme of “Future Makers,” the Summit is designed as a platform where ambition, scientific progress, and clinical expertise come together. It brings together a global community of clinicians who are not only adopting innovation but actively driving changes in how implant dentistry is practiced. Due to strong interest, nearly all Summit masterclasses are already fully booked or close to reaching capacity.

The Summit’s scientific program is designed around the themes of Growth, Efficiency, and Outcomes, reflecting the mindset of clinicians who are ready to shape what comes next in implant dentistry.

Growth: Advancing Scientific Exchange and Clinical Education

The Summit program includes scientific sessions and masterclasses covering topics such as peri-implantitis management, esthetic treatment approaches, ridge augmentation, and full-arch rehabilitation. Led by internationally recognized clinicians and researchers, these sessions are designed to support evidence-based learning and professional exchange among implant dentistry professionals.

Efficiency: Exploring Digital and Integrated Workflows

Several sessions will focus on digital workflows and integrated treatment approaches in implant dentistry. Topics will include digital planning, guided surgery protocols, and connected workflows designed to support communication, treatment planning, and clinical efficiency in daily practice.

Outcomes: Supporting Predictable, Patient-Centered Treatment

The scientific program will also address clinical decision-making and long-term treatment outcomes through discussions on complication management, biomaterials, immediacy protocols, and multidisciplinary care. These sessions aim to provide clinicians with practical insights to support predictable and patient-centered implant treatment approaches.

Inspiration Hub: Where Innovation Comes to Life

The exhibition area will serve as a meeting point for Future Makers to connect with product experts, explore the latest implant solutions, and experience digital workflows firsthand. The Inspiration Hub will showcase innovations across implant systems, prosthetic solutions, regenerative materials, and DS Core.

“The Implant Solutions World Summit is where clinicians come together not just to learn but to shape what comes next as they are looking for solutions that help them grow, improve efficiency, and deliver predictable results. The Summit creates the environment to exchange ideas, challenge thinking, and ultimately move implant dentistry forward,” said Xavier Carro, Senior VP EMEA RCO & Global Lead for Henry Schein.

For last-minute registrations, visit: www.dentsplysirona.com/worldsummit

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands.

Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast,” and similar words and expressions. However, these words are not the exclusive means of identifying such statements.

In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market, and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.

Registered brands, trade names and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials. Due to the different approval and registration times, not all technologies and products are immediately available in all countries. Please reach out to a local dealer or sales representative for more information.

Source: http://www.dentsplysirona.com/worldsummit

Related articles

Dentsply Sirona, the world’s largest diversified manufacturer of professional dental products and technologies, is expanding its digital solutions for dental laboratories with the


Bioceramic ProRoot Bio Sealer and AH Plus Ribbon give practitioners the confidence they need to successfully perform endodontic treatments


On World Oral Health Day (WOHD), Dentsply Sirona highlights the essential role dental professionals play in supporting healthier lives and reinforces that oral health is an integral part of overall...


Taking place April 10-11, 2026, at the DS Academy in Charlotte, North Carolina, this immersive symposium will bring together orthodontists, clinicians, and team members to explore the evolving...


Reciproc Minima, the next generation of the Reciproc family of endodontic files from Dentsply Sirona, are engine-driven endodontic instruments made of nickel-titanium alloy used to mechanically shape...


Read more

CaviSense Inc., a Harvard/Tufts spin-out and developer of a radiation-free diagnostic technology for active tooth demineralization.


Colgate-Palmolive (NYSE:CL) Chief Operating Officer, Americas, Shane Grant, and Executive Vice President, M&A and Special Projects, John Faucher, will participate in a fireside cha


This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


Your website is your virtual storefront and, more often than not, a patient’s first impression of your practice.


 
 
 
 

 
 
 
 

Most popular

 
 

Events